Literature DB >> 3289570

Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.

K Tanaka1, T Yoshioka, C Bieberich, G Jay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3289570     DOI： 10.1146/annurev.iy.06.040188.002043

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN： 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  57 in total

1.  CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.

Authors:  M Boesen; I M Svane; A M Engel; J Rygaard; A R Thomsen; O Werdelin
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.

Authors:  W J Storkus; R D Salter; J Alexander; F E Ward; R E Ruiz; P Cresswell; J R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Familial CD8 deficiency due to a mutation in the CD8 alpha gene.

Authors:  O de la Calle-Martin; M Hernandez; J Ordi; N Casamitjana; J I Arostegui; I Caragol; M Ferrando; M Labrador; J L Rodriguez-Sanchez; T Espanol
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

Authors:  T Aoki; K Tashiro; S Miyatake; T Kinashi; T Nakano; Y Oda; H Kikuchi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas.

Authors:  Z Végh; P Wang; F Vánky; C Hising; K Sjöwall; B Larsson; E Klein
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

7.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

Authors:  V A Kuznetsov; I A Makalkin; M A Taylor; A S Perelson
Journal:  Bull Math Biol       Date:  1994-03       Impact factor: 1.758

8.  Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.

Authors:  L Lanza; L Peirano; O Bosco; P Contini; G Filaci; M Setti; F Puppo; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

9.  Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.

Authors:  M E Sunday; K J Isselbacher; S Gattoni-Celli; C G Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Authors:  Y Watanabe; K Kuribayashi; S Miyatake; K Nishihara; E Nakayama; T Taniyama; T Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.